Follow
Sourav Roy
Title
Cited by
Cited by
Year
Equilibrium unfolding of cyclophilin from Leishmania donovani: Characterization of intermediate states
S Roy, S Basu, AK Datta, D Bhattacharyya, R Banerjee, D Dasgupta
International journal of biological macromolecules 69, 353-360, 2014
142014
Capturing a crucial ‘disorder-to-order transition’at the heart of the coronavirus molecular pathology—triggered by highly persistent, interchangeable salt-bridges
S Roy, P Ghosh, A Bandyopadhyay, S Basu
Vaccines 10 (2), 301, 2022
112022
Anion formation by electron impact from CF4
SVK Kumar, MA Rahman, S Roy
International Journal of Mass Spectrometry 277 (1-3), 57-61, 2008
92008
Targeting the initiator protease of the classical pathway of complement using fragment-based drug discovery
BR Rushing, DL Rohlik, S Roy, DA Skaff, BL Garcia
Molecules 25 (17), 4016, 2020
82020
The unfolding MD simulations of cyclophilin: analyzed by surface contact networks and their associated metrics
S Roy, S Basu, D Dasgupta, D Bhattacharyya, R Banerjee
Plos one 10 (11), e0142173, 2015
42015
Conformational dynamics of complement protease C1r inhibitor proteins from Lyme disease–and relapsing fever–causing spirochetes
S Roy, CE Booth, AD Powell-Pierce, AM Schulz, JT Skare, BL Garcia
Journal of Biological Chemistry 299 (8), 2023
32023
CuI@graphene as antibody-free fluorosensor for prostate-specific antigen (PSA)
DDSBNRSRBHK Sen
Materials Today Chemistry 26 (101196), 1-11, 2022
1*2022
Inhibition of the C1s Protease and the Classical Complement Pathway by 6-(4-Phenylpiperazin-1-yl) Pyridine-3-Carboximidamide and Chemical Analogs
X Xu, TJ Herdendorf, H Duan, DL Rohlik, S Roy, H Zhou, H Alkhateeb, ...
The Journal of Immunology, 2024
2024
The system can't perform the operation now. Try again later.
Articles 1–8